Cormorant Asset Management

Cormorant Asset Management as of Dec. 31, 2016

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 77 positions in its portfolio as reported in the December 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Proteostasis Therapeutics In 6.3 $47M 3.8M 12.26
Theravance Biopharma (TBPH) 6.1 $45M 1.4M 31.88
Nevro (NVRO) 5.9 $44M 601k 72.66
Alder Biopharmaceuticals 4.4 $33M 1.6M 20.80
Eagle Pharmaceuticals (EGRX) 4.4 $33M 410k 79.34
Minerva Neurosciences 4.2 $31M 2.7M 11.75
Ardelyx (ARDX) 4.0 $29M 2.1M 14.20
Aclaris Therapeutics (ACRS) 3.6 $27M 976k 27.14
Heron Therapeutics (HRTX) 3.5 $26M 2.0M 13.10
Blueprint Medicines (BPMC) 3.2 $24M 842k 28.05
Galapagos Nv- (GLPG) 2.9 $21M 334k 64.09
Corbus Pharmaceuticals Hldgs 2.9 $21M 2.5M 8.45
Clearside Biomedical (CLSD) 2.8 $21M 2.3M 8.94
Myokardia 2.5 $19M 1.4M 12.95
Protagonist Therapeutics (PTGX) 2.1 $16M 720k 21.99
Coherus Biosciences (CHRS) 2.0 $15M 519k 28.15
Quotient 1.9 $14M 2.9M 4.84
Neurocrine Biosciences (NBIX) 1.9 $14M 359k 38.70
Wave Life Sciences (WVE) 1.8 $13M 508k 26.15
China Biologic Products 1.6 $12M 113k 107.52
Portola Pharmaceuticals 1.6 $12M 537k 22.44
Inc Resh Hldgs Inc cl a 1.4 $11M 200k 52.60
Array BioPharma 1.4 $10M 1.2M 8.79
Fulgent Genetics (FLGT) 1.3 $9.9M 858k 11.57
Omeros Corporation (OMER) 1.3 $9.7M 975k 9.92
Sorrento Therapeutics (SRNE) 1.3 $9.4M 1.9M 4.90
Synergy Pharmaceuticals 1.2 $9.1M 1.5M 6.09
Audentes Therapeutics 1.1 $8.2M 450k 18.27
Ultragenyx Pharmaceutical (RARE) 1.1 $7.8M 111k 70.31
Zynerba Pharmaceuticals 1.0 $7.5M 481k 15.59
Curis 1.0 $7.4M 2.4M 3.08
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 1.0 $7.1M 456k 15.57
Gemphire Therapeutics 0.9 $7.1M 900k 7.84
Rigel Pharmaceuticals 0.9 $6.8M 2.9M 2.38
Contrafect 0.9 $6.7M 3.8M 1.75
Agenus 0.8 $5.9M 1.4M 4.12
Pfenex 0.8 $5.7M 633k 9.07
Concert Pharmaceuticals I equity 0.8 $5.5M 538k 10.29
Dex (DXCM) 0.7 $5.4M 90k 59.70
Dermira 0.7 $5.2M 172k 30.33
Forward Pharma A/s 0.7 $5.1M 339k 15.01
Recro Pharma 0.7 $4.9M 603k 8.06
Intec Pharma 0.6 $4.6M 810k 5.70
Invuity 0.6 $4.4M 768k 5.75
Cytomx Therapeutics (CTMX) 0.6 $4.1M 372k 10.99
Sunesis Pharmaceuticals Inc Ne 0.5 $3.6M 1.0M 3.62
Advanced Accelerat spon ads each rep 2 ord 0.5 $3.3M 124k 26.76
Acceleron Pharma 0.4 $3.3M 128k 25.52
Ascendis Pharma A S (ASND) 0.4 $3.3M 162k 20.24
Agile Therapeutics 0.4 $3.2M 564k 5.70
Catabasis Pharmaceuticals 0.4 $2.9M 800k 3.61
Regenxbio Inc equity us cm (RGNX) 0.4 $2.9M 157k 18.55
Corvus Pharmaceuticals (CRVS) 0.4 $2.8M 199k 14.30
Lipocine 0.4 $2.8M 751k 3.68
Xencor (XNCR) 0.3 $2.6M 100k 26.32
Aquinox Pharmaceuticals 0.3 $2.5M 152k 16.51
Oncobiologics 0.3 $2.5M 833k 3.01
Abeona Therapeutics 0.3 $2.4M 500k 4.85
Immune Design 0.3 $2.4M 433k 5.50
Avexis 0.3 $2.4M 50k 47.73
Sangamo Biosciences (SGMO) 0.3 $2.0M 650k 3.05
Epizyme 0.3 $1.9M 160k 12.10
Tigenix 0.2 $1.9M 129k 14.58
Glycomimetics (GLYC) 0.2 $1.8M 287k 6.10
Syndax Pharmaceuticals (SNDX) 0.2 $1.7M 240k 7.17
Aptose Biosciences 0.2 $1.4M 991k 1.39
Myovant Sciences 0.2 $1.2M 100k 12.44
Nanostring Technologies (NSTGQ) 0.1 $903k 41k 22.30
AVEO Pharmaceuticals 0.1 $587k 1.1M 0.54
Threshold Pharmaceuticals 0.1 $445k 1.0M 0.44
Htg Molecular Diagnostics 0.1 $456k 204k 2.24
Neos Therapeutics 0.0 $296k 51k 5.85
Oncobiologics Inc *w exp 05/18/201 0.0 $329k 417k 0.79
Applied Genetic Technol Corp C 0.0 $162k 17k 9.35
Cellectar Biosciences 0.0 $65k 54k 1.21
Oncobiologics Inc *w exp 02/18/201 0.0 $79k 417k 0.19
Cellectar Biosciences Equity Warrants *w 0.0 $10k 53k 0.19